TOURMALINE-MM3 and 4: Ixazomib as Maintenance Therapy in Myeloma Patients

Sagar Lonial, MD, provides an update on TOURMALINE-MM3 and 4, which are looking at the role of ixazomib as maintenance therapy in patients with newly diagnosed myeloma.

SHARE